Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
  1. Home
  2. Programs
  3. ACC Action Center

APOC3 ASO significantly lowers triglycerides in patients with hypertriglyceridemia and high CV risk

Brian Bergmark at the ACC24
Restart
Resume
Choose a format
Media formats available:
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Details
Presenters
Comments
  • Overview

    ACC.24 - Brian Bergmark discusses the results of the BRIDGE-TIMI 73a trial in patients with either moderate hypertriglyceridemia and elevated CV risk or with severe hypertriglyceridemia. “Olezarsen reduced triglycerides levels to an extent that is greater than currently available drugs”.

  • Educational information

    This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.

  • Faculty

    Brian Bergmark, MD is an Associate Physician in Interventional Cardiology in the Division of Cardiovascular Medicine at the Brigham and Women's Hospital, Boston, MA, US. He also is an Assistant Professor of Medicine at Harvard Medical School in Boston, MA, US.

  • Disclaimer

Recommended
Details
Presenters
Comments
  • Overview

    ACC.24 - Brian Bergmark discusses the results of the BRIDGE-TIMI 73a trial in patients with either moderate hypertriglyceridemia and elevated CV risk or with severe hypertriglyceridemia. “Olezarsen reduced triglycerides levels to an extent that is greater than currently available drugs”.

  • Educational information

    This video was recorded in response to a presentation at the Congress of the American College of Cardiology (ACC) 2024.

  • Faculty

    Brian Bergmark, MD is an Associate Physician in Interventional Cardiology in the Division of Cardiovascular Medicine at the Brigham and Women's Hospital, Boston, MA, US. He also is an Assistant Professor of Medicine at Harvard Medical School in Boston, MA, US.

  • Disclaimer

Schedule15 Oct 2024